Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
超越數字：11位分析師討論塞德斯醫療股票
In the preceding three months, 11 analysts have released ratings for Celldex Therapeutics (NASDAQ:CLDX), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 5 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 4 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Celldex Therapeutics, presenting an average target of $68.55, a high estimate of $80.00, and a low estimate of $45.00. This current average has decreased by 3.45% from the previous average price target of $71.00.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間